Labanzo L 400mg/150mg Tablet
By Labanzo L
Rx
1 Tablet in a Strip

Composition
Albendazole(400mg) + Levamisole(150mg)

Manufacturer - Zelnic Biotech Pvt Ltd
SCF- 596, Motor Market, Sector 5 Chandigarh - 160101, India

Expires on or after
October, 2025

liver
When using Labanzo L 400mg/150mg Tablet, it is important to be cautious if you have liver disease. Patients with liver conditions should use this medication carefully and may require dose adjustments. It is recommended to consult your doctor before starting treatment with Labanzo L 400mg/150mg Tablet. Additionally, if you experience symptoms of jaundice such as yellowing of the eyes and skin, itching, or clay-colored stools while taking this medication, inform your doctor immediately.

kidney
Labanzo L 400mg/150mg Tablet appears safe for patients with kidney disease. Limited data indicates no need for dose adjustments in these patients. Consult your doctor for guidance.

alcohol
Consult your doctor when consuming alcohol with Labanzo L 400mg/150mg Tablet.

driving
When taking Labanzo L 400mg/150mg Tablet, be cautious while driving as it may reduce alertness, cause drowsiness, affect vision, and induce dizziness. Avoid driving if experiencing these effects.

pregnancy
Labanzo L 400mg/150mg Tablet should be avoided during pregnancy as it may be harmful to the developing baby, based on animal studies. Consult your doctor for a thorough evaluation of benefits and risks before using this medication.

breastfeeding
Labanzo L 400mg/150mg Tablet is likely safe during breastfeeding, based on limited data showing no significant risk to the baby.
Habit Forming | No |
Chemical Class | - |
Therapeutic Class | ANTI INFECTIVES |
Action Class | - |
₹27
Inclusive of all taxes
Content verified by

Dr. Gowri Kulkarni
MBBS - General Medicine, DNB - Psychiatry, MRCGP [INT] Family Medicine, BSIC (BACP)
Last update on 01-Oct-2024